KUSHITANI KEI

J-GLOBAL         Last updated: Aug 3, 2019 at 02:52
 
Avatar
Name
KUSHITANI KEI
E-mail
kkushihiroshima-u.ac.jp
Affiliation
Hiroshima University
Degree
Doctor of Philosophy in Medical Science(Hiroshima University)
Research funding number
00508179

Research Areas

 
 

Academic & Professional Experience

 
Apr 2008
 - 
Mar 2019
Research associate, Graduate School of Biomedical Sciences, Hiroshima University
 

Education

 
Apr 2003
 - 
Feb 2008
Hiroshima University
 
Apr 1997
 - 
Mar 2003
Faculty of Medicine, Hiroshima University
 

Published Papers

 
Kushitani, Kei; Amatya, Vishwa Jeet; Mawas, Amany Sayed; Miyata, Yoshihiro; Okada, Morihito; Takeshima, Yukio
PATHOBIOLOGY   83(1) 33-40   2016   [Refereed]
Objectives: The histological differential diagnosis between epithelioid mesothelioma (EM) and reactive mesothelial hyperplasia (RMH) is not always straightforward. The aim of the present study was to search for new immunohistochemical markers to d...
Prognostic significance of vascular invasion in intermediate-grade subtype of lung adenocarcinoma
Tsubokawa N, Mimae T, Miyata Y, Sasada S, Yoshiya T, Kushitani K, Takeshima Y, Murakami S, Yokose T, Ito H, Nakayama H, Okada M.
Japanese Journal of Clinical Oncology      Aug 2016   [Refereed]
Prognostic Role of Subtype Classification in Small-Sized Pathologic N0 Invasive Lung Adenocarcinoma
Yoshiya T, Mimae T, Tsutani Y, Tsubokawa N, Sasada S, Miyata Y, Kushitani K, Takeshima Y, Murakami S, Ito H, Nakayama H, Okada M.
The Annals of Thoracic Surgery      Jun 2016   [Refereed]
Amatya, Vishwa Jeet; Mawas, Amany Sayed; Kushitani, Kei; El-Din, Mouchira M. Mohi; Takeshima, Yukio
INTERNATIONAL JOURNAL OF ONCOLOGY   48(4) 1599-1607   Apr 2016   [Refereed]
Malignant mesothelioma is a highly aggressive cancer with poor prognosis and refractory to currently available therapies. Most of the patients with advanced invasive nature are not amenable to surgical resection and/or available anticancer therapy...
Furukawa, Takaoki; Miyata, Yoshihiro; Kushitani, Kei; Mimae, Takahiro; Tsutani, Yasuhiro; Takeshima, Yukio; Okada, Morihito
JAPANESE JOURNAL OF CLINICAL ONCOLOGY   45(12) 1154-1161   Dec 2015   [Refereed]
Objective: High maximum standardized uptake values on [F-18]-fluoro-2-deoxyglucose positron emission tomography are associated with inferior survival in non-small cell lung cancer. Here, we investigated the biological mechanisms underlying [F-18]-...

Conference Activities & Talks

 
MiR-1, MiR-214 reduces cell proliferation and invasion in mesothelioma cells
Amatya V.J.,Mawas Amany S.,櫛谷 桂,武島幸男
第56回日本肺癌学会学術集会   26 Nov 2015   
肉腫型中皮腫の病理診断における免疫組織化学的染色の有用性と諸問題 [Invited]
武島幸男,Amatya V.J.,櫛谷 桂
第22回石綿・中皮腫研究会   31 Oct 2015   
A Case of Fetal Lung Interstitial Tumor
Kei Kushitani, Yukio Takeshima
The 104th Annual Meeting of The Japanese Society of Pathology   2 May 2015   
Immunohistochemical analyses of pooly differentiated epithelioid mesothelioma and lung carcinomas
Kei Kushitani, Yuki Naito, Hiroto Shimajiri, Amatya Vishwa Jeet, Yukio Takeshima
The 104th Annual Meeting of The Japanese Society of Pathology   1 May 2015   
Functional analysis of miR-214 transfection on mesothelioma cell lines
Amany S.M.,Amatya V.J.,櫛谷 桂,武島幸男
30 Apr 2015